Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Turcot syndrome × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 3 Lung Neoplasms 2 Unresectable Hepatocellular Carcinoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor Cancer 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoplasms 1 Neoadjuvant Immunotherapy 1 Muscle-invasive Bladder Cancer 1 Locally Advanced Pancreatic Cancer 1 Hyperthermia 1 HER2-Negative Locally Advanced Breast Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Advanced Rectal Cancer 1

Interventions

pembrolizumab 3 sintilimab 1 Surgical Procedures, Operative 1 Nivolumab 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 DEAE-Dextran 1 Colonoscopy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07259473 2026-01-07

Pre-CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Turcot syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡